333 related articles for article (PubMed ID: 7511983)
1. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
Gupta S; Patel K; Singh H; Gollapudi S
Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
[TBL] [Abstract][Full Text] [Related]
2. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S
Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837
[TBL] [Abstract][Full Text] [Related]
3. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN
Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024
[TBL] [Abstract][Full Text] [Related]
4. Role of protein kinase beta isozyme in multidrug resistance in murine leukemia P388/ADR cells.
Gollapudi S; Soni V; Thadepalli H; Gupta S
J Chemother; 1995 Apr; 7(2):157-9. PubMed ID: 7666124
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport.
Gollapudi S; Patel K; Jain V; Gupta S
Cancer Lett; 1992 Feb; 62(1):69-75. PubMed ID: 1347251
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
[TBL] [Abstract][Full Text] [Related]
7. Effect of the protein kinase C inhibitor staurosporine on chemosensitivity to daunorubicin of normal and leukemic fresh myeloid cells.
Laredo J; Huynh A; Muller C; Jaffrézou JP; Bailly JD; Cassar G; Laurent G; Demur C
Blood; 1994 Jul; 84(1):229-37. PubMed ID: 7912555
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
9. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
Nagasawa K; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
Biol Pharm Bull; 1996 Jul; 19(7):971-6. PubMed ID: 8839972
[TBL] [Abstract][Full Text] [Related]
10. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
Kessel D; Wilberding C
Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
[TBL] [Abstract][Full Text] [Related]
13. Exploring multidrug resistance using rhodamine 123.
Kessel D
Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
[TBL] [Abstract][Full Text] [Related]
14. Induction of resistance to daunorubicin in drug-sensitive leukemia p388 cells - a role of pkc-Beta-I isozyme.
Gollapudi S; Deniega J; Soni V; Gupta S
Int J Oncol; 1994 Dec; 5(6):1227-31. PubMed ID: 21559702
[TBL] [Abstract][Full Text] [Related]
15. Selective photodynamic inactivation of a multidrug transporter by a cationic photosensitising agent.
Kessel D; Woodburn K
Br J Cancer; 1995 Feb; 71(2):306-10. PubMed ID: 7841045
[TBL] [Abstract][Full Text] [Related]
16. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
Gollapudi S; Gupta S
Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
[TBL] [Abstract][Full Text] [Related]
17. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ
Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900
[TBL] [Abstract][Full Text] [Related]
18. Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell line.
Urasaki Y; Ueda T; Nakamura T
Jpn J Cancer Res; 1994 Jun; 85(6):659-64. PubMed ID: 7914886
[TBL] [Abstract][Full Text] [Related]
19. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
[TBL] [Abstract][Full Text] [Related]
20. Effects of protein kinase C modulators on multidrug resistance in human glioma cells.
Matsumoto T; Tani E; Yamaura I; Miyaji K; Kaba K
Neurosurgery; 1995 Mar; 36(3):565-71; discussion 572. PubMed ID: 7538636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
